Andrew C. Wood, MBChB

Andrew C. Wood, MBChB, is an attending physician in the Cancer Center at The Children’s Hospital of Philadelphia.

Locations: Main Campus
Appointments and Referrals: 1-800-TRY-CHOP (1-800-879-2467)

  • Education and Training

    Medical School

    MBChB - University of Auckland, School of Medicine, Grafton, Auckland, New Zealand


    Pediatrics - Starship Children’s Hospital, Grafton, Auckland, New Zealand


    Pediatric Hematology-Oncology - The Children's Hospital of Philadelphia, Philadelphia, PA

    Additional Training

    Postdoctoral Fellowship - The Children's Hospital of Philadelphia, Philadelphia, PA

    Board Certification


  • Titles and Academic Titles

    Attending Physician

  • Publications



    Bresler SC, Wood AC, Haglund EA, Courtright J, Belcastro LT, Plegaria JS, et al. Differential inhibitor sensitivity of anaplastic lymphoma kinase variants found in neuroblastoma. Sci Transl Med 2011 Nov 9. Cited in PubMed; PMID: 22072639. Read the article

    Cole KA, Huggins J, Laquaglia M, Hulderman CE, Russell MR, Bosse K, et al. RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma. Proc Natl Acad Sci U S A. 2011 Feb 22;108(8):3336-41. Cited in PubMed; PMID: 21289283. Read the article


    Balamuth NJ, Wood A, Wang Q, Jagannathan J, Mayes P, Zhang Z, et al. Serial transcriptome analysis and cross-species integration identifies centromere-associated protein E as a novel neuroblastoma target. Cancer Res. 2010 Mar 16. Cited in PubMed; PMID: 20233875. Read the article


    Mossé YP, Wood A, Maris JM. Inhibition of ALK signaling for cancer therapy. Clin Cancer Res. 2009 Sep 15;15 (18):5609-14. Cited in PubMed; PMID: 19737948. Read the article

    Diskin SJ, Hou C, Glessner JT, Attiyeh EF, Laudenslager M, Bosse K, et al. Copy number variation at 1q21.1 associated with neuroblastoma. Nature. 2009 Jun 18;459 (7249):987-91. Cited in PubMed; PMCID: PMC2755253. Read the article